Neuraxis (NRXS) Change in Inventory (2022 - 2025)
Neuraxis (NRXS) posted Change in Inventory of $152607.0 for Q4 2025, up 1693.31% sequentially from -$9578.0 in Q3 2025, and up 422.05% YoY from $29232.0 in Q4 2024.
Neuraxis (NRXS) Change in Inventory (2022 - 2025) Analysis & Trends
Neuraxis has reported Change in Inventory for 4 years, with the latest figure at $152607.0 in Q4 2025.
- Quarterly Change in Inventory rose 422.05% year-over-year to $152607.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $242874.0 (up 647.3% YoY) and the FY2025 annual result came in at $242874.0, up 647.3% from the prior year.
- Change in Inventory rose to $152607.0 in Q4 2025 per NRXS's latest filing, from -$9578.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $152607.0 in Q4 2025 and troughed at -$32813.0 in Q2 2023.
- A 4-year average of $17414.1 and a median of -$3966.5 in 2024 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 422.05% in 2025, down 573.2% in 2025.
- Over 4 years, Change in Inventory stood at -$9188.0 in 2022, then slumped by 44.86% to -$13310.0 in 2023, then soared by 319.62% to $29232.0 in 2024, then jumped by 422.05% to $152607.0 in 2025.
- According to Business Quant data, Change in Inventory over the past three periods registered $152607.0, -$9578.0, and $106752.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Neuraxis | 74.54 Mn | 66.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 152,607.00 |
| Dec 31, 2025 | 152,607.00 |
| Sep 30, 2025 | -9,578.00 |
| Sep 30, 2025 | -9,578.00 |
| Jun 30, 2025 | 106,752.00 |
| Jun 30, 2025 | 106,752.00 |
| Mar 31, 2025 | -6,907.00 |
| Mar 31, 2025 | -6,907.00 |
| Dec 31, 2024 | 29,232.00 |
| Dec 31, 2024 | 29,232.00 |
| Sep 30, 2024 | -18,222.00 |
| Sep 30, 2024 | -18,222.00 |
| Jun 30, 2024 | 22,516.00 |
| Jun 30, 2024 | 22,516.00 |
| Mar 31, 2024 | -1,026.00 |
| Mar 31, 2024 | -1,026.00 |
| Dec 31, 2023 | -13,310.00 |
| Dec 31, 2023 | -13,310.00 |
| Sep 30, 2023 | -9,675.00 |
| Sep 30, 2023 | -9,675.00 |